IQV - IQVIA Holdings Inc.

NYSE - NYSE Verzögerter Preis. Währung in USD

IQVIA Holdings Inc.

4820 Emperor Boulevard
Durham, NC 27703
United States
919-998-2000
http://www.iqvia.com

SektorHealthcare
BrancheDiagnostics & Research
Vollzeitmitarbeiter65.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Ari BousbibChairman, Pres & CEO8,44M42,51M1961
Mr. Michael R. McDonnellExec. VP & CFO1,31MN/A1964
Mr. Eric M. SherbetExec. VP, Gen. Counsel & Sec.912,94kN/A1964
Mr. W. Richard Staub IIIPres of R&D Solutions1,24MN/A1963
Mr. Kevin C. KnightlyPres of Information & Technology Solutions1,13M1,03M1961
Die Beträge haben den Stand 31. Dezember 2018 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. IQVIA Holdings Inc. serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Corporate Governance

IQVIA Holdings Inc.s ISS Governance QualityScore, Stand 4. Oktober 2019, lautet 10. Die grundlegenden Scores sind Audit: 2, Vorstand: 9, Shareholderrechte: 10, Kompensation: 10.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.
Mit Yahoo Nutzung stimmen Sie zu, dass Yahoo und Partner Cookies für Personalisierungs- und andere Zwecke nutzen